TAK1-mediated transcriptional activation of CD28-responsive element and AP-1-binding site within the IL-2 promoter in Jurkat T cells

FEBS Letters

Volumn 579, Issue 29, 2005, Pages 6641-6646

  Sakurai, Hiroaki ^a   Singhirunnusorn, Pattama ^a   Shimotabira, Emi ^a   Chino, Atsushi ^a,b   Suzuki, Shunsuke ^a   Koizumi, Keiichi ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

IL 2; T cell; TAB1; TAK1

Indexed keywords

BINDING PROTEIN; CALCIMYCIN; CD28 ANTIGEN; I KAPPA B KINASE; INTERLEUKIN 2; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1 BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD28; BINDING SITES; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MAP KINASE KINASE KINASES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); REGULATORY ELEMENTS, TRANSCRIPTIONAL; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

EID: 27944448381     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.10.059     Document Type: Article

References (31)

1. Z. Jiang, J. Ninomiya-Tsuji, Y. Qian, K. Matsumoto, and X. Li Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol Mol. Cell. Biol. 22 2002 7158 7167
2. T. Ishitani, G. Takaesu, J. Ninomiya-Tsuji, H. Shibuya, R.B. Gaynor, and K. Matsumoto Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling EMBO J. 22 2003 6277 6288
3. H. Sakurai, H. Miyoshi, W. Toriumi, and T. Sugita Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation J. Biol. Chem. 274 1999 10641 10648
4. T. Irie, T. Muta, and K. Takeshige TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide- stimulated macrophages FEBS Lett. 467 2000 160 164
5. H. Sakurai, A. Nishi, N. Sato, J. Mizukami, H. Miyoshi, and T. Sugita TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways Biochem. Biophys. Res. Commun. 297 2002 1277 1281
6. G. Takaesu, R.M. Surabhi, K.J Park, J. Ninomiya-Tsuji, K. Matsumoto, and R.B. Gaynor TAK1 is critical for IkappaB kinase-mediated activation of the NF-κB pathway J. Mol. Biol. 326 2003 105 115
7. G. Takaesu, R.M. Surabhi, K.J. Park, J. Ninomiya-Tsuji, K. Matsumoto, and R.B. Gaynor TAK1 is critical for IkappaB kinase-mediated activation of the NF-κB pathway J. Mol. Biol. 326 2003 105 115
8. C. Wang, L. Deng, M. Hong, G.R. Akkaraju, J. Inoue, and Z.I. Chen TAK1 is a ubiquitin-dependent kinase of MKK and IKK Nature 412 2001 346 351
9. S. Vidal, S.R. Khush, F. Leulier, P. Tzou, and M. Nakamura Mutations in the drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-κB-dependent innate immune responses Genes Dev. 15 2001 1900 1912
10. J.M. Park, H. Brady, M.G. Ruocco, H. Sun, D. Williams, S.J. Lee, T. Kato Jr., N. Richards, K. Chan, F. Mercurio, M. Karin, and S.A. Wasserman Targeting of TAK1 by the NF-κB protein relish regulates the JNK-mediated immune response in drosophila Genes Dev. 18 2004 584 594
11. L. Sun, L. Deng, C.K. Ea, Z.P. Xia, and Z.J. Chen The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in Tlymphocytes Mol. Cell. 14 2004 289 301
12. T. Che, Y. You, D. Wang, M.J. Tanner, V.M. Dixit, and X. Lin MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation J. Biol. Chem. 279 2004 15870 15876
13. D. Wang, Y. You, S.M. Case, L.M. McAllister-Lucas, L. Wang, P.S. DiStefano, G. Nunez, J. Bertin, and X. Lin A requirement for CARMA1 in TCR-induced NF-κB activation Nat. Immunol. 3 2002 830 835
14. L.X. Wu, J. La Rose, L. Chen, C. Neale, T. Mak, K. Okkenhaug, R. Wange, and R.J. Rottapel CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway Immunology 174 2005 180 194
15. M. Sanchez-Lockhart, E. Marin, B. Graf, R. Abe, Y. Harada, C.E. Sedwick, and J.J. Miller Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways Immunology 173 2004 7120 7124
16. N. Coudronniere, M. Villalba, N. Englund, and A. Altman NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta Proc. Natl. Acad. Sci. USA 97 2000 3394 3399
17. E.W. Harhaj, S.B. Maggirwar, L. Good, and S.C. Sun CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers Mol. Cell. Biol. 16 1996 6736 6743
18. X. Lin, E.T. Cunningham Jr., Y. Mu, R. Geleziunas, and W.C. Greene The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases Immunity 10 1999 271 280
19. S.P. Hehner, T.G. Hofmann, O. Dienz, W. Droge, and M.L. Schmitz Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription J. Biol. Chem. 275 2000 18160 18171
20. S.P. Hehner, T.G. Hofmann, A. Ushmorov, O. Dienz, I. Wing-Lan Leung, N. Lassam, C. Scheidereit, W. Droge, and M.L. Schmitz Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IκB kinase complex Mol. Cell. Biol. 20 2000 2556 2568
21. B. Su, J. Cheng, J. Yang, and Z. Guo MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression J. Biol. Chem. 276 2001 14784 14790
22. S.J. Kempiak, T.S. Hiura, and A.E. Nel The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the IκB kinase cascade J. Immunol. 162 1999 3176 3187
23. J.H. Lai, G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T.H. Tan RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter Mol. Cell. Biol. 15 1995 4260 4271
24. C.L. Verweij, M. Geerts, and L.A. Aarden Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element J. Biol. Chem. 266 1991 14179 14182
25. V.S. Shapiro, K.E. Truitt, J.B. Imboden, and A. Weiss CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites Mol. Cell. Biol. 17 1997 4051 4058
26. P. Singhirunnusorn, S. Suzuki, N. Kawasaki, I. Saiki, and H. Sakurai Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-β-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2 J. Biol. Chem. 280 2005 7359 7368
27. H. Sakurai, Y. Hisada, M. Ueno, M. Sugiura, K. Kawashima, and T. Sugita Activation of transcription factor NF-κB in experimental glomerulonephritis in rats Biochim. Biophys. Acta 1316 1996 132 138
28. G.. Takaesu, S. Kishida, A. Hiyama, K. Yamaguchi, H. Shibuya, K. Irie, J. Ninomiya-Tsuji, and K. Matsumoto TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway Mol. Cell 5 2000 649 658
29. C.C. Wu, S.C. Hsu, H.M. Shih, and M.Z. Lai Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells Mol. Cell. Biol. 23 2003 6442 6454
30. A. Thiefes, S. Wolter, J.F. Mushinski, E. Hoffmann, O. Dittrich-Breiholz, N. Graue, A. Dorrie, H. Schneider, D. Wirth, B. Luckow, K. Resch, and M. Kracht Simultaneous blockade of NFκB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis target genes J. Biol. Chem. 280 2005 27728 27741
31. J. Ninomiya-Tsuji, T. Kajino, K. Ono, T. Ohtomo, M. Matsumoto, M. Shiina, M. Mihara, M. Tsuchiya, and K. Matsumoto A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase J. Biol. Chem. 278 2003 18485 18490